Lyubov Kiseleva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lyubov Kiseleva has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
A V Kartashev
6 shared publicationsA. V. Kartashev
Russian Research Center for Radiology and Surgical Technologies Named after A.M. Granov
5 shared publicationsN. L. Vartanyan
Russian Research Center for Radiology and Surgical Technologies Named after A.M. Granov
5 shared publications- A. A. Pinevich
Granov Russian Research Center for Radiology and Surgical Technologies, St. Petersburg, Russia
4 shared publications M. P. Samoilovich
Russian Research Center for Radiology and Surgical Technologies Named after A.M. Granov
4 shared publicationsA S Iagunov
3 shared publications
Latest Publications
- 21 February 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 2,p. 5-12
Analysis of indocyanine green plasma disappearance rate in clinical practice
OBJECTIVE To justify the optimal method for determining indocyanine green plasma disappearance rate (PDRICG). MATERIAL AND METHODS We analyzed PDRICG in intensive care units. Indocyanine green was administered intravenously at a dose of 0.25 mg/kg. PDRICG was analyzed simultaneously by using of three methods: 1) PDD (PiCCO2 LiMON device), 2) SBS with analysis of plasma samples on precise spectrophotometer, 3) SBS with analysis of plasma samples on simple experimental photometer. RESULTS PDD method was used for 346 PDRICG tests in 256 patients. Of these, 14.3% of measurements were erroneous. Paired tests using PDD and SBS methods were performed in 299 cases. SBS method resulted erroneous data in 0.6% of cases. Certain correlation (r=0.79, pICG of the PDD method (for example, more than 30%/min). Comparison of two SBS variants (spectrophotometer and experimental photometer) revealed good correlation (r=0.91, pICG ensures accurate results under mechanical interferences in patients with impaired capillary blood flow. This eliminates the need for redo measurement. Duplication of the PDD and SBS methods is recommended when repeating the test is not possible (organ donors).
- 21 February 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 2,p. 5-12
Analysis of indocyanine green plasma disappearance rate in clinical practice
OBJECTIVE To justify the optimal method for determining indocyanine green plasma disappearance rate (PDRICG). MATERIAL AND METHODS We analyzed PDRICG in intensive care units. Indocyanine green was administered intravenously at a dose of 0.25 mg/kg. PDRICG was analyzed simultaneously by using of three methods: 1) PDD (PiCCO2 LiMON device), 2) SBS with analysis of plasma samples on precise spectrophotometer, 3) SBS with analysis of plasma samples on simple experimental photometer. RESULTS PDD method was used for 346 PDRICG tests in 256 patients. Of these, 14.3% of measurements were erroneous. Paired tests using PDD and SBS methods were performed in 299 cases. SBS method resulted erroneous data in 0.6% of cases. Certain correlation (r=0.79, pICG of the PDD method (for example, more than 30%/min). Comparison of two SBS variants (spectrophotometer and experimental photometer) revealed good correlation (r=0.91, pICG ensures accurate results under mechanical interferences in patients with impaired capillary blood flow. This eliminates the need for redo measurement. Duplication of the PDD and SBS methods is recommended when repeating the test is not possible (organ donors).
- Open Access
- 1 January 2024
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 11 (1) , 105-118
Construction of oncolytic reporter influenza viral vectors and assessment of their safety following intracranial administration in rats
INTRODUCTION: Oncolytic viruses are a promising approach for treating malignant brain tumors as part a of combination therapy. OBJECTIVE: To develop reporter influenza A viruses expressing NanoLuc luciferase and evaluate their safety following intracranial administration in rats. METHODS: Chemiluminescent reporter influenza A virus strains were obtained by reverse genetics. The NS genetic segment of the T_NS124-Luc and E_NS124-Luc strains encoded a fusion protein that combined NS1124 and NanoLuc. In the T_NS124-2A-Luc and E_NS124-2A-Luc strains, the NS1124 and NanoLuc sequences were separated by a 2A co-translational cleavage site. To enhance the tumor specificity of the viruses, the trypsin cleavage site (T) in the hemagglutinin (HA) protein was replaced with an elastase cleavage site (E) by introducing S342→P and R343→I substitutions in the HA region of the E_NS124-Luc and E_NS124-2A-Luc constructs. RESULTS: The obtained constructs demonstrated comparable reproductive and luminescent activity in MDCK cells. However, vectors containing the 2A site upstream of the transgene infected the glioma cell lines C6, A172, and T98G more effectively. Intracranial administration of a high dose of the virus was safe, causing no neurological or other pathological symptoms in rats. In addition, the luminescent reporter NanoLuc was expressed at the injection site without the formation of active viral progeny. CONCLUSION: This study demonstrated that a chemiluminescent influenza A virus strain can induce transgene expression at the site of intracranial injection without active viral replication.
- 1 January 2024
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 11 (1) , 105-118
Open AccessConstruction of oncolytic reporter influenza viral vectors and assessment of their safety following intracranial administration in rats
INTRODUCTION: Oncolytic viruses are a promising approach for treating malignant brain tumors as part a of combination therapy. OBJECTIVE: To develop reporter influenza A viruses expressing NanoLuc luciferase and evaluate their safety following intracranial administration in rats. METHODS: Chemiluminescent reporter influenza A virus strains were obtained by reverse genetics. The NS genetic segment of the T_NS124-Luc and E_NS124-Luc strains encoded a fusion protein that combined NS1124 and NanoLuc. In the T_NS124-2A-Luc and E_NS124-2A-Luc strains, the NS1124 and NanoLuc sequences were separated by a 2A co-translational cleavage site. To enhance the tumor specificity of the viruses, the trypsin cleavage site (T) in the hemagglutinin (HA) protein was replaced with an elastase cleavage site (E) by introducing S342→P and R343→I substitutions in the HA region of the E_NS124-Luc and E_NS124-2A-Luc constructs. RESULTS: The obtained constructs demonstrated comparable reproductive and luminescent activity in MDCK cells. However, vectors containing the 2A site upstream of the transgene infected the glioma cell lines C6, A172, and T98G more effectively. Intracranial administration of a high dose of the virus was safe, causing no neurological or other pathological symptoms in rats. In addition, the luminescent reporter NanoLuc was expressed at the injection site without the formation of active viral progeny. CONCLUSION: This study demonstrated that a chemiluminescent influenza A virus strain can induce transgene expression at the site of intracranial injection without active viral replication.
- Open Access
- 1 January 2024
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 11 (1) , 105-118
Конструирование репортерных гриппозных онколитических векторов и оценка их безопасности при интракраниальном введении у крыс
ВВЕДЕНИЕ: Онколитические вирусы представляют собой перспективный инструмент для лечения злокачественных опухолей головного мозга в составе комплексной терапии. ЦЕЛЬ ИССЛЕДОВАНИЯ: Разработка репортерных рекомбинантных вирусов гриппа А, экспрессирующих люциферазу NanoLuc, и оценка их безопасности при интракраниальном введении у крыс. МЕТОДЫ: Репортерные штаммы вируса гриппа А, обладающие хемилюминесцентной активностью, были получены методом обратной генетики. Генетический сегмент NS штаммов Т_NS124-Luc и Е_NS124-Luc кодировал слитую белковую последовательность NS1124 вируса гриппа и NanoLuc. В штаммах Т_NS124-2А-Luc и Е_NS124-2А-Luc белок-кодирующие последовательности были разделены 2А сайтом, обеспечивающим ко-трансляционное разделение белков. Для повышения специфичности вирусов к опухолевым клеткам в двух конструкциях (Е_NS124-Luc и Е_NS124-2А-Luc) в сайт протеолитического расщепления гемагглютинина были внесены точечные мутации S342→P и R343→I, приводящие к замене сайта протеолитического расщепления с трипсинового (T) на эластазный (E). РЕЗУЛЬТАТЫ: Все исследованные конструкции имели сопоставимую репродуктивную и люминесцентную активность при культивировании в клетках MDCK. Однако при инфицировании клеточных линий глиом (С6, A172 и T98G) векторы с 2А сайтом перед трансгеном продемонстрировали более высокий потенциал роста. Интракраниальное введение высокой дозы вируса крысам было безопасным и не вызывало неврологических и других патологических симптомов. При этом люминесцентный репортер NanoLuc экспрессировался в месте введения, без формирования инфекционного вирусного потомства. ЗАКЛЮЧЕНИЕ: Показана возможность экспрессии трансгена в зоне интракраниального введения репортерного штамма вируса гриппа А, обладающего хемилюминесцентной активностью, в отсутствии активной вирусной репликации.
- 1 January 2024
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 11 (1) , 105-118
Open AccessКонструирование репортерных гриппозных онколитических векторов и оценка их безопасности при интракраниальном введении у крыс
ВВЕДЕНИЕ: Онколитические вирусы представляют собой перспективный инструмент для лечения злокачественных опухолей головного мозга в составе комплексной терапии. ЦЕЛЬ ИССЛЕДОВАНИЯ: Разработка репортерных рекомбинантных вирусов гриппа А, экспрессирующих люциферазу NanoLuc, и оценка их безопасности при интракраниальном введении у крыс. МЕТОДЫ: Репортерные штаммы вируса гриппа А, обладающие хемилюминесцентной активностью, были получены методом обратной генетики. Генетический сегмент NS штаммов Т_NS124-Luc и Е_NS124-Luc кодировал слитую белковую последовательность NS1124 вируса гриппа и NanoLuc. В штаммах Т_NS124-2А-Luc и Е_NS124-2А-Luc белок-кодирующие последовательности были разделены 2А сайтом, обеспечивающим ко-трансляционное разделение белков. Для повышения специфичности вирусов к опухолевым клеткам в двух конструкциях (Е_NS124-Luc и Е_NS124-2А-Luc) в сайт протеолитического расщепления гемагглютинина были внесены точечные мутации S342→P и R343→I, приводящие к замене сайта протеолитического расщепления с трипсинового (T) на эластазный (E). РЕЗУЛЬТАТЫ: Все исследованные конструкции имели сопоставимую репродуктивную и люминесцентную активность при культивировании в клетках MDCK. Однако при инфицировании клеточных линий глиом (С6, A172 и T98G) векторы с 2А сайтом перед трансгеном продемонстрировали более высокий потенциал роста. Интракраниальное введение высокой дозы вируса крысам было безопасным и не вызывало неврологических и других патологических симптомов. При этом люминесцентный репортер NanoLuc экспрессировался в месте введения, без формирования инфекционного вирусного потомства. ЗАКЛЮЧЕНИЕ: Показана возможность экспрессии трансгена в зоне интракраниального введения репортерного штамма вируса гриппа А, обладающего хемилюминесцентной активностью, в отсутствии активной вирусной репликации.
- 1 January 2022
- Published by Springer Nature
- p. 415-420
Infrared Finger-Piece Sensor for ICG Concentration Measurements
- 1 January 2022
- Published by Springer Nature
- p. 415-420
Infrared Finger-Piece Sensor for ICG Concentration Measurements
- Open Access
- 2 September 2020
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 3
Prognostic value of selected hypercoagulability markers in sepsis. A prospective study
Introduction. Sepsis is a heterogeneous syndrome caused by an unbalanced host response to an infection, resulting in organ dysfunction. Disseminated intravascular coagulation (DIC) varies widely from 30 % to 60 % and depends on different scoring systems. An overt DIC easily identified, while the pre-existing phase of hypercoagulability can’t be detected by screening coagulation tests. Preventive DIC treatment is hardly possible without an early diagnostics. Objectives. The aim of the study is identifying the hypercoagulabiliy markers in septic patients with hypercoagulability pattern on thromboelastometry (TEM) and matching them to the outcome. Materiasl and methods. ROTEM screening of septic patients revealed 85 ones with pattern of hypercoagulability. Thrombin generation test with thrombomodulin, screening coagulation tests, anticoagulants levels and selected hypercoagulability markers were performed from frozen plasma samples. According to the outcome patients were divided to survivors and nonsurvivors. Results. The survivors group included 62 patients and nonsurvivors — 19. Thrombin generation test revealed only 7 cases of hypercoagulability. There was no significant difference in endogenous thrombin potential 20 (10; 25) % vs 14 (10; 31) % and peak thrombin 8 (2,9; 16) % vs 7 (3; 18) % in survivors and nonsurvivors, respectively. Other significant differences between survivors vs nonsurvivors are: protein C 79,5 ± 28 % vs 64,9 ± 25 %, FVIII 226,4 ± 66 % vs 276,6 ± 94 % , von Willebrand factor 269 ± 129 % vs 435 ± 181 %, Аntithrombin 82 (60; 94) % vs 65 (41; 80) %, and D-dimer 2157 (1341; 3964) mcg/l vs 3253 (1911; 6914) mcg/l, respectively. Conclusion. Septic patients with TEM criteria of hypercoagulability may have unique set of thrombophilia markers. Local screening coagulation tests do not affect the prognosis. Low level of protein C and antithrombin, as well as high FVIII, von Willebrand factor, D-dimer worsen outcome.
- 2 September 2020
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 3
Open AccessPrognostic value of selected hypercoagulability markers in sepsis. A prospective study
Introduction. Sepsis is a heterogeneous syndrome caused by an unbalanced host response to an infection, resulting in organ dysfunction. Disseminated intravascular coagulation (DIC) varies widely from 30 % to 60 % and depends on different scoring systems. An overt DIC easily identified, while the pre-existing phase of hypercoagulability can’t be detected by screening coagulation tests. Preventive DIC treatment is hardly possible without an early diagnostics. Objectives. The aim of the study is identifying the hypercoagulabiliy markers in septic patients with hypercoagulability pattern on thromboelastometry (TEM) and matching them to the outcome. Materiasl and methods. ROTEM screening of septic patients revealed 85 ones with pattern of hypercoagulability. Thrombin generation test with thrombomodulin, screening coagulation tests, anticoagulants levels and selected hypercoagulability markers were performed from frozen plasma samples. According to the outcome patients were divided to survivors and nonsurvivors. Results. The survivors group included 62 patients and nonsurvivors — 19. Thrombin generation test revealed only 7 cases of hypercoagulability. There was no significant difference in endogenous thrombin potential 20 (10; 25) % vs 14 (10; 31) % and peak thrombin 8 (2,9; 16) % vs 7 (3; 18) % in survivors and nonsurvivors, respectively. Other significant differences between survivors vs nonsurvivors are: protein C 79,5 ± 28 % vs 64,9 ± 25 %, FVIII 226,4 ± 66 % vs 276,6 ± 94 % , von Willebrand factor 269 ± 129 % vs 435 ± 181 %, Аntithrombin 82 (60; 94) % vs 65 (41; 80) %, and D-dimer 2157 (1341; 3964) mcg/l vs 3253 (1911; 6914) mcg/l, respectively. Conclusion. Septic patients with TEM criteria of hypercoagulability may have unique set of thrombophilia markers. Local screening coagulation tests do not affect the prognosis. Low level of protein C and antithrombin, as well as high FVIII, von Willebrand factor, D-dimer worsen outcome.
- Open Access
- 16 August 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (8) , 599
Design of Liver Functional Reserve Estimation Technique Based on Optical Densitometry
This work is aimed at creating a modified invasive technique for assessing the liver’s functional reserves. A study of the degree of hepatodepression is carried out by measuring the plasma elimination of indocyanine green using the method of optical densitometry. This paper presents test results for an aqueous solution and an albumin solution, as well as the results of measurements of plasma elimination of indocyanine green for patients with liver disease. Perfecting the proposed method will make an important scientific contribution to modern diagnostic medicine. Diagnosing the stages in the progression of the disease and its developing complications can make it possible to rapidly correct the patient’s treatment algorithm, achieving positive outcomes in medical practice.
- 16 August 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (8) , 599
Open AccessDesign of Liver Functional Reserve Estimation Technique Based on Optical Densitometry
This work is aimed at creating a modified invasive technique for assessing the liver’s functional reserves. A study of the degree of hepatodepression is carried out by measuring the plasma elimination of indocyanine green using the method of optical densitometry. This paper presents test results for an aqueous solution and an albumin solution, as well as the results of measurements of plasma elimination of indocyanine green for patients with liver disease. Perfecting the proposed method will make an important scientific contribution to modern diagnostic medicine. Diagnosing the stages in the progression of the disease and its developing complications can make it possible to rapidly correct the patient’s treatment algorithm, achieving positive outcomes in medical practice.
- 1 March 2018
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 12 (2) , 93-101
The Effect of Fotemustine on Human Glioblastoma Cell Lines
Glioblastomas are a heterogeneous group of tumors of neuroectodermal origin. Tumor cell cultures obtained from patients with glioblastomas differ in morphology and phenotype, as well as genetic...
- 1 March 2018
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 12 (2) , 93-101
The Effect of Fotemustine on Human Glioblastoma Cell Lines
Glioblastomas are a heterogeneous group of tumors of neuroectodermal origin. Tumor cell cultures obtained from patients with glioblastomas differ in morphology and phenotype, as well as genetic...
- 1 January 2018
- Published by Pleiades Publishing Ltd in Citologiâ
- Vol. 60 (1)
FOTEMUSTINE EFFECT ON HUMAN GLIOBLASTOMA CELL LINES
- 1 January 2018
- Published by Pleiades Publishing Ltd in Citologiâ
- Vol. 60 (1)
FOTEMUSTINE EFFECT ON HUMAN GLIOBLASTOMA CELL LINES
- 1 January 2018
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 12 (1) , 1-6
Characterization of New Human Glioblastoma Cell Lines
Glioblastomas are tumors of neuroectodermal origin with a high degree of diversity. Tumor cells isolated from the surgical material of patients with glioblastomas are heterogeneous populations...
- 1 January 2018
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 12 (1) , 1-6
Characterization of New Human Glioblastoma Cell Lines
Glioblastomas are tumors of neuroectodermal origin with a high degree of diversity. Tumor cells isolated from the surgical material of patients with glioblastomas are heterogeneous populations...
- 1 September 2016
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 10 (5) , 341-348
A172 and T98G cell lines characteristics
During prolonged cultivation, cell lines may lose a number of innate characteristics or acquire new ones. In this work, we compared growth and phenotypic characteristics of human glioblastoma А172...
- 1 September 2016
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 10 (5) , 341-348
A172 and T98G cell lines characteristics
During prolonged cultivation, cell lines may lose a number of innate characteristics or acquire new ones. In this work, we compared growth and phenotypic characteristics of human glioblastoma А172...